{
    "startDate": "2017-01-01",
    "endDate": "2017-06-30",
    "year": "2017",
    "quarter": "Q2",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents, beginning of the period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1169500000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 1723500000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1630200000
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DuefromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 502900000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 936500000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 1146100000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 7108700000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesNoncurrent",
                "unit": "usd",
                "value": 2632700000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 2827600000
            },
            {
                "label": "Intangible assets",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 4051300000
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 3870400000
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1268300000
            },
            {
                "label": "Assets:",
                "concept": "Assets",
                "unit": "usd",
                "value": 21759000000
            },
            {
                "label": "Current portion of notes payable and other financing arrangements",
                "concept": "DebtCurrent",
                "unit": "usd",
                "value": 559900000
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 52600000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 330300000
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2436900000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3379700000
            },
            {
                "label": "Notes payable and other financing arrangements",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 5954000000
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 100800000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 750900000
            },
            {
                "label": "Liabilities:",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10185400000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 19300000
            },
            {
                "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -338800000
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 14881700000
            },
            {
                "label": "Treasury stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000
            },
            {
                "label": "Equity increase during the period",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 11585200000
            },
            {
                "label": "NCI, beginning of period",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -11600000
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 11573600000
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 21759000000
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 1610300000
            },
            {
                "label": "Depreciation, amortization and acquired in-process research and development",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 814600000
            },
            {
                "label": "Equity Award [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 67300000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -20500000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -73500000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 301200000
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 85300000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": -452300000
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": -114700000
            },
            {
                "label": "Other changes in operating assets and liabilities, net",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 187300000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 1404400000
            },
            {
                "label": "Proceeds from maturities and sales",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 3584500000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecurities",
                "unit": "usd",
                "value": 2536000000
            },
            {
                "label": "Contingent consideration related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 600000000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 120000000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 407700000
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 860300000
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": 7300000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -946800000
            },
            {
                "label": "Payments for repurchase of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 1365400000
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 17800000
            },
            {
                "label": "Net cash contribution to Bioverativ Inc.",
                "concept": "PaymentsOfCapitalDistribution",
                "unit": "usd",
                "value": 302700000
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 33500000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -1652400000
            },
            {
                "label": "Net (decrease) increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -1194800000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 37800000
            }
        ],
        "ic": [
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 1610400000
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 5600000
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": -126800000
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": 500000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 102800000
            },
            {
                "label": "Other comprehensive income:",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -18900000
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 1591500000
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 1591400000
            },
            {
                "label": "Product, net",
                "concept": "SalesRevenueGoodsNet",
                "unit": "usd",
                "value": 5019800000
            },
            {
                "label": "Revenues from anti-CD20 therapeutic programs",
                "concept": "biib:RevenuesfromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 737700000
            },
            {
                "label": "Other",
                "concept": "OtherSalesRevenueNet",
                "unit": "usd",
                "value": 131600000
            },
            {
                "label": "Revenues:",
                "concept": "Revenues",
                "unit": "usd",
                "value": 5889100000
            },
            {
                "label": "Cost of sales",
                "concept": "CostOfGoodsSold",
                "unit": "usd",
                "value": 750800000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 1219600000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 929300000
            },
            {
                "label": "Amortization of acquired intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 566000000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 120000000
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:Collaborationprofitlosssharing",
                "unit": "usd",
                "value": 47300000
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": -31200000
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cost and expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 3664200000
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 2224900000
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -105800000
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 2119100000
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 508800000
            },
            {
                "label": "Equity in loss of investee, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 1610300000
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -100000
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 7.53
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 7.52
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 213700000
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 214000000
            }
        ]
    }
}